rs111033570
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_012210.4(TRIM32):c.1459G>A(p.Asp487Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. D487D) has been classified as Likely benign.
Frequency
Consequence
NM_012210.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRIM32 | NM_012210.4 | c.1459G>A | p.Asp487Asn | missense_variant | 2/2 | ENST00000450136.2 | |
ASTN2 | NM_001365068.1 | c.2806+26570C>T | intron_variant | ENST00000313400.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRIM32 | ENST00000450136.2 | c.1459G>A | p.Asp487Asn | missense_variant | 2/2 | 1 | NM_012210.4 | P1 | |
ASTN2 | ENST00000313400.9 | c.2806+26570C>T | intron_variant | 5 | NM_001365068.1 | A2 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251384Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135916
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727246
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
Sarcotubular myopathy Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 05, 2012 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Jul 10, 2023 | - - |
Pathogenic, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Dec 03, 2018 | The homozygous p.Asp487Asn variant in TRIM32 was identified by our study in one individual with limb-girdle muscular dystrophy (LGMD). This variant has been identified in 0.001791% (2/111664) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs111033570). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The p.Asp487Asn variant in TRIM32 has been reported in 55 Hutterite individuals with LGMD and segregated with disease in 8 affected relatives from 3 families (PMID: 11822024, 15786463). Animal models in mice have shown that this variant causes Limb-Girdle Muscular Dystrophy by lowering protein stability but not mRNA levels. Knock-in mice with this variant showed a similar neuromuscular phenotype to trim32 knock-out mice, supporting pathogenicity as a loss of function variant (PMID: 21775502). This variant has also been reported pathogenic in ClinVar by multiple submitters (Variation ID: 7350). In summary, the p.Asp487Asn variant is pathogenic. ACMG/AMP Criteria applied: PM2, PP1_Strong, PS3 (Richards 2015). - |
Bardet-Biedl syndrome 11 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2016 | This variant was classified as: Pathogenic. This variant was detected in homozygous state. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 22, 2019 | - - |
Myopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Apr 08, 2015 | - - |
Bardet-Biedl syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 487 of the TRIM32 protein (p.Asp487Asn). This variant is present in population databases (rs111033570, gnomAD 0.002%). This missense change has been observed in individual(s) with limb-girdle muscular dystrophy type 2H and sarcotubular myopathy (PMID: 11822024, 15786463, 23142638). It is commonly reported in individuals of Hutterite ancestry (PMID: 11822024, 15786463, 23142638). ClinVar contains an entry for this variant (Variation ID: 7350). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects TRIM32 function (PMID: 21775502). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at